Dr Kat Goodall
Honorary (Fellow)
Department of Paediatrics
14 Scholarly works
0 Projects
HIGHLIGHTS
2024
Journal article
Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activity
DOI: 10.1016/j.celrep.2024.1148342024
Journal article
Erratum: NK cell heparanase controls tumor invasion and immune surveillance (The Journal of clinical investigation PII: e183295)
DOI: 10.1172/JCI1832952022
Journal article
Heparanase is a regulator of natural killer cell activation and cytotoxicity
DOI: 10.1002/JLB.3A0420-259RR2021
Journal article
Ribosylation of the CD8αβ heterodimer permits binding of the nonclassical major histocompatibility molecule, H2-Q10
DOI: 10.1016/j.jbc.2021.1011412020
Journal article
The murine CD94/NKG2 ligand, Qa-1b, is a high-affinity, functional ligand for the CD8αα homodimer
DOI: 10.1074/jbc.RA119.0105092019
Journal article
The expanding role of murine class Ib MHC in the development and activation of Natural Killer cells
DOI: 10.1016/j.molimm.2018.05.0012019
Journal article
Structural basis for the recognition of nectin-like protein-5 by the human-activating immune receptor, DNAM-1
DOI: 10.1074/jbc.RA119.009261
RECENT SCHOLARLY WORKS
2019
Journal article
Multiple receptors converge on H2-Q10 to regulate NK and γδT-cell development
DOI: 10.1111/imcb.122222017
Journal article
NK cell heparanase controls tumor invasion and immune surveillance
DOI: 10.1172/JCI929582016
Journal article
Cycloheximide can induce bax/bak dependent myeloid cell death independently of multiple BH3-only proteins
DOI: 10.1371/journal.pone.0164003